CD163 and neoplasm: This study showed that although tumor-associated CD66b(+) neutrophils and CD163(+) macrophages were correlated with adverse prognostic factors in NSCLC—such as a higher CRP, a higher white blood cell count, larger tumor size, and necrosis—no direct link to the patients’ outcome was observed [29].